AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting riskPopularity #4,449

ARAY · NASDAQ · Medical - Devices

Accuray (ARAY)

Builds radiation-treatment systems, planning software, and services around the CyberKnife and TomoTherapy platforms.

$0.2295

vs last close−0.00 (−0.22%)

In millions of USD, except per-share figures

In millions	Q1 FY24Sep 2023	Q2 FY24Dec 2023	Q3 FY24Mar 2024	Q4 FY24Jun 2024	Q1 FY25Sep 2024	Q2 FY25Dec 2024	Q3 FY25Mar 2025	Q4 FY25Jun 2025	Q1 FY26Sep 2025	Q2 FY26Dec 2025	Q3 FY26Mar 2026	Q4 FY26Jun 2026
Revenue	104	107	101	134	102	116	113	128	94	102	105	101
Cost of revenue	64	71	72	96	67	74	82	89	67	78	80	65
Gross profit	39	36	29	38	34	42	32	39	27	24	25	36
	37	40	34	32	37	37	31	35	38	30	28	43
Research & development	14	15	11	10	12	14	11	11	11	11	8	8
	23	25	23	22	25	24	20	23	26	19	20	19
Selling & marketing	10	11	10	11	12	11	9	11	12	9	8	9
General & administrative	13	13	12	11	13	12	11	12	15	10	11	10
Other expenses	0	0	0	0	0	0	0	0	0	0	0	16
Operating income	2	−4	−5	7	−2	5	1	4	−11	−5	−3	−7
	−3	−5	−1	−3	−1	−1	−2	−2	−10	−8	−9	6
Interest income	0	0	0	0	0	0	0	0	0	0	0	0
Interest expense	3	3	3	3	3	3	15	4	8	8	8	11
Other non-operating income	0	2	−2	0	−2	−1	−1	−2	2	0	0	−14
Income before tax	−1	−9	−6	4	−3	3	−1	2	−21	−13	−11	−2
Income tax expense	2	1	0	0	1	1	0	1	0	1	0	0
Net income from continuing operations	−3	−10	−6	3	−4	3	−1	1	−22	−14	−12	−2
Net income	−3	−10	−6	3	−4	3	−1	1	−22	−14	−12	−2
EPS, basic	−$0.03	−$0.10	−$0.06	$0.03	−$0.04	$0.03	−$0.01	$0.01	−$0.18	−$0.11	−$0.09	−$0.02
EPS, diluted	−$0.03	−$0.10	−$0.06	$0.03	−$0.04	$0.02	−$0.01	$0.01	−$0.18	−$0.11	−$0.09	−$0.02
Weighted average shares, basic	97	98	99	100	100	101	103	107	119	120	124	123
Weighted average shares, diluted	97	98	99	101	100	104	103	109	119	120	124	123
EBITDA	3	−4	−1	8	1	8	4	8	−10	−3	−1	0
Depreciation & amortization	1	2	2	2	1	2	2	2	3	2	2	−7
EBIT	2	−6	−3	7	0	6	2	6	−13	−5	−3	7